Tumor cell vaccination and IL-2 therapy.
Ahlert
T
T
Department of Gynecology and Obstetrics, University of Heidelberg, Germany.
D000951:Antigens, Neoplasm / Q000008:administration & dosage / Q000302:isolation & purification; D001943:Breast Neoplasms / Q000628:therapy; D002985:Clinical Protocols; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D007376:Interleukin-2 / Q000008:administration & dosage / Q000627:therapeutic use*; D009369:Neoplasms / Q000276:immunology / Q000628:therapy*; D009522:Newcastle disease virus / Q000276:immunology; D010051:Ovarian Neoplasms / Q000628:therapy; D014611:Vaccination / Q000379:methods*; D014612:Vaccines / Q000008:administration & dosage / Q000302:isolation & purification
D000951:Antigens, Neoplasm; D007376:Interleukin-2; D014612:Vaccines